Valérie Gouilleux-Gruart Selected Research

neonatal Fc receptor

10/2021	Neonatal Fc receptor expression in lymphoid and myeloid cells in systemic lupus erythematosus.
1/2020	The neonatal Fc receptor in cancer FcRn in cancer.
1/2016	Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis.
5/2015	The neonatal Fc receptor does not modulate hepatitis C virus neutralization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Valérie Gouilleux-Gruart Research Topics

Disease

7	Neoplasms (Cancer) 01/2020 - 02/2011
4	Thrombocytopenia (Thrombopenia) 07/2020 - 08/2012
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2017 - 08/2007
3	Colorectal Neoplasms (Colorectal Cancer) 11/2016 - 10/2011
3	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2016 - 02/2003
2	Crohn Disease (Crohn's Disease) 06/2021 - 05/2015
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020 - 01/2017
2	Breast Neoplasms (Breast Cancer) 05/2016 - 05/2011
2	Hematologic Neoplasms (Hematological Malignancy) 10/2013 - 02/2011
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2021
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2020
1	Vasculitis (Vasculitides) 01/2020
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2020
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2020
1	Nasal Polyps (Nasal Polyp) 03/2019
1	Asthma (Bronchial Asthma) 03/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019
1	Acute Erythroblastic Leukemia (Erythroleukemia) 01/2019
1	Rheumatoid Arthritis 01/2017
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2017
1	Neutropenia 01/2017
1	Neoplasm Metastasis (Metastasis) 11/2016
1	Colonic Neoplasms (Colon Cancer) 01/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016
1	Inflammation (Inflammations) 05/2015
1	Virus Diseases (Viral Diseases) 05/2015
1	Thrombosis (Thrombus) 04/2015
1	Hemophilia A (Haemophilia) 02/2015
1	Body Weight (Weight, Body) 01/2015
1	Atypical Hemolytic Uremic Syndrome 01/2015
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 11/2012
1	Disease Progression 10/2011
1	Anemia 12/2006
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 12/2006
1	Lymphadenopathy 12/2006
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2005
1	Cytopenia 11/2004
1	Eosinophilia 12/2003

Drug/Important Bio-Agent (IBA)

7	Immunoglobulin G (IgG)IBA 06/2021 - 12/2006
6	Monoclonal AntibodiesIBA 01/2020 - 01/2016
5	Rituximab (Mabthera)FDA Link 01/2020 - 01/2017
4	neonatal Fc receptorIBA 10/2021 - 05/2015
4	AntibodiesIBA 01/2020 - 11/2004
4	Proteins (Proteins, Gene)FDA Link 01/2016 - 02/2003
3	Heparin (Liquaemin)FDA LinkGeneric 07/2020 - 08/2012
2	Infliximab (Remicade)FDA Link 06/2021 - 05/2015
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2020 - 01/2020
2	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 12/2006
2	Fc Receptors (Fc Receptor)IBA 01/2020 - 04/2015
2	eculizumab FDA Link 01/2016 - 01/2015
2	Cetuximab (Erbitux)FDA Link 12/2015 - 10/2011
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2013 - 07/2005
1	Biological ProductsIBA 10/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2020
1	Myeloblastin (Proteinase 3)IBA 01/2020
1	Serine Proteases (Serine Protease)IBA 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 12/2019
1	Transferrin (beta 2 Transferrin)IBA 01/2019
1	IronIBA 01/2019
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2019
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	CD20 AntigensIBA 01/2017
1	Carcinoembryonic AntigenIBA 11/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2016
1	Bevacizumab (Avastin)FDA Link 11/2016
1	Trastuzumab (Herceptin)FDA Link 05/2016
1	Epidermal Growth Factor (EGF)IBA 05/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Complement C5 (Complement 5)IBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2015
1	AntigensIBA 02/2015
1	Factor VIII (Coagulation Factor VIII)IBA 02/2015
1	Immunodominant EpitopesIBA 02/2015
1	Complement System Proteins (Complement)IBA 01/2015
1	Transcription Factors (Transcription Factor)IBA 10/2013
1	Immune Sera (Antisera)IBA 08/2013
1	Inosine Triphosphate (ITP)IBA 11/2012
1	Platelet Factor 4IBA 08/2012
1	Protein Tyrosine PhosphatasesIBA 08/2012
1	Irinotecan (Camptosar)FDA LinkGeneric 10/2011
1	Fluorouracil (Carac)FDA LinkGeneric 10/2011
1	Insulin (Novolin)FDA Link 05/2011
1	HSP40 Heat-Shock ProteinsIBA 02/2011
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 08/2007
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2004
1	AutoantibodiesIBA 11/2004
1	Intravenous Immunoglobulins (IVIG)FDA Link 11/2004
1	SteroidsIBA 11/2004
1	Peptides (Polypeptides)IBA 11/2004
1	ChemokinesIBA 12/2003
1	CytokinesIBA 12/2003

Therapy/Procedure

3	Therapeutics 03/2019 - 01/2015
2	Transplantation 01/2020 - 01/2017
2	Radioimmunotherapy 01/2020 - 01/2017
1	Induction Chemotherapy 01/2017